Bioactive natural products from mangrove-derived actinomycetes are important sources for discovery of drug lead compounds. In this study, an extract prepared from culture of an actinomycete Streptomyces sp. ZQ4BG isolated from mangrove soils was found to have activity in inhibiting proliferation of glioma cells. Large culture of this mangrove actinomycete in Gause's liquid medium resulted in isolation of seven novel polyene-polyol macrolides, named as flavofungins III-IX (3-9), together with known flavofungins I (1) and II (2) and spectinabilin (10). Structures of these isolated compounds were elucidated by extensive NMR analyses and HRESIMS data. The stereochemical assignments were achieved by a combination of NOE information, universal NMR database, and chemical reactions including preparation of acetonide derivatives and Mosher esters. Flavofungins IV-VIII (4-8) are rare 32-membered polyene-polyol macrolides with a tetrahydrofuran ring, while flavofungin IX (9) represents the first example of this type of macrolide with a unique oxepane ring. Flavofungins I (1) and II (2) and spectinabilin (10) showed anti-glioma and antifungal activities.
, ten bacterial strains were isolated from a sample of mangrove soils. An extract prepared from the culture of strain ZQ4BG was found to be the most active against the proliferation of glioma cells with an inhibition of 56.9% for U87MG and 48.9% for U251. This mangrove-derived strain was assigned as Streptomyces sp. ZQ4BG based on its 16S rDNA sequence ( Supplementary Information, Fig. S1 ), which completely (99% identity for a 1404 bp stretch of sequence) matched those of two species of Streptomyces including S. fulvissimus and S. flavofungini (Table S1) in GenBank database. The actinomycete S. flavofungini was previously reported to produce polyene-polyol flavofungins 16 and polyol macrolides of desertomycins 17 . Polyene-polyol macrolides are usually microbial metabolites whose main structural elements are a continuously conjugated chain of four to seven unsubstituted double bonds connected to a polyol fragment with alternating hydroxy groups. Nystatin, produced by Streptomyces noursei, was the first polyene-polyol macrolide showing antifungal and antibacterial activities 18, 19 . Amphotericin B, a heptaene-polyol macrolide produced by S. nodosus, is a standard antifungal drug for treating serious deep-seated systemic fungal infections 20 . Most of the polyene-polyol macrolides discovered since are produced by a variety of terrestrial Streptomyces spp., such as mycoticins from S. ruber 21 sp. 87-397 [22] [23] [24] , nystatins from S. noursei 25 , and reedsmycins from Streptomyces sp. CHQ-64 26 . Recently, polyene-polyol macrolides were also isolated from marine actinomycetes, such as marinisporolides from marine Marinispora sp. CNQ140 27 and bahamaolides from marine Streptomyces sp 28 . Some of these polyene-polyol macrolides mentioned above were found to have significant antifungal, antibacterial, antiviral, and antitumor activities [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . A HPLC analysis of the active extract from strain ZQ4BG revealed that this mangrove-derived actinomycete produced rich metabolites with similar UV absorption (λ max ) at 365 nm or 330 nm. 4 with UV absorption at 365 nm were match to those of known flavofungins I (1) and II (2) , respectively, in AntiBase database 29 and references 30, 31 . The others with m/z 675.4, 689.4, 703.4, and 707.4 with λ max 330 nm did not match any previously reported compounds, prompting us to characterize them further. Therefore, large culture of this isolated mangrove-derived strain ZQ4BG in Gause's liquid medium resulted in isolation and identification of a series of polyene-polyol macrolides, including new flavofungins III-IX (3) (4) (5) (6) (7) (8) (9) and known flavofungins I (1) and II (2) and spectinabilin (10) . Flavofungins IV-VIII (4-8) are rare 32-membered polyene-polyol macrolides with a tetrahydrofuran ring, while flavofungin IX (9) is the first example of this type of macrolide with a unique oxepane group. Herein, we report the isolation and culture of strain ZQ4BG, the structural elucidation of these novel flavofungins, and the anti-glioma and antimicrobial active evaluation of these isolated metabolites.
Results and Discussion
An actinomycete strain ZQ4BG which produced rich polyene-polyol macrolides was isolated from mangrove soils and assigned as Streptomyces sp. ZQ4BG based on the result of its 16S rDNA sequence. Culture (total 60 L) of this isolated actinomycete in Gause's liquid medium resulted in isolation of compounds 1-10 ( Fig. 1) .
Compounds 1, 2, and 10 were proved to be known compounds of flavofungins I (1) and II (2) 30, 31 and spectinabilin (10) 32-34 based on their HRESIMS and NMR data (Tables 1 and 2 ) as well as a comparison to the data of references. Flavofungins I (1) and II (2) were 32-membered polyene-polyol macrolides with a conjugated chain of five unsubstituted double bonds connected to a polyol fragment with eight hydroxy groups alternated. Both Scientific RepoRts | 7: 1703 | DOI:10.1038/s41598-017-01912-z flavofungins I (1) and II (2) were reported to have antifungal and antiviral activities 19 , while spectinabilin (10) was a nitro-substituted polyketide with activity to block the binding of androgen to the ligand-binding domain of androgen receptor 34 . Compounds 3-9 are new members of flavofungins I (1) and II (2), with only four unsubstituted conjugated double bonds and more oxygenated moieties, and named as flavofungins III-IX (3-9). Flavofungin III (3) is an analogue of flavofungin I (1) with two hydroxy groups substituted at C-10 and C-11. Flavofungins IV-IX (4-9) are rare 32-membered polyene-polyol macrolides with a tetrahydrofuran (THF) ring between C-10 and C-13 for flavofungins IV-VIII (4) (5) (6) (7) (8) or an oxepane ring between C-10 and C-15 for flavofungin IX (9) . It has been found that new flavofungins III-IX (3-9) might derive from known flavofungins I (1) and II (2) , suggesting all flavofungins produced by strain ZQ4BG might have same biosynthetic pathway. A hypothetical mechanism for the formation of 3-9 from 1 and 2 is proposed in Fig. S2 (Supplementary Information). The 10,11-epoxide compounds (Fig. S2B ) might be formed by enzymatic epoxidation of the double bond at C 10 and C 11 ( Fig. S2A) , followed by hydrolysis of these epoxides to give corresponding 10,11-dihydroxylated compounds (Fig. S2C ) 35, 36 . New flavofungins IV-IX (4-9, Fig. S2D and E) might derive from 10,11-dihydroxylated compounds by cyclization at C-10 and C-13 or C-10 and C-15. The exact structures of these new flavofungins were elucidated based on their HRESIMS data and extensive NMR spectroscopic analyses. The stereochemical assignments were made by a combination of NOE information, 1 13 C, 1 H-1 H COSY, HSQC, and HMBC concluded that these three compounds shared a same planar structure, which is a 32-membered macrolide with four unsubstituted conjugated double bonds at C-2 to C-9, one double bond at C-28 and C-29, 11 oxymethines at C-10, C-11, C-13, C-15, C-17, C-19, C-21, C-23, C-25, C-27 and C-31, two methyls at C-14 and C-30, one isopropyl at C-31, and a tetrahydrofuran (THF) ring between C-10 and C-13. All double bonds in 4, 6, and 7 were assigned as E geometries based on their trans-coupling constants (≥14.8 Hz, Tables 2 and 3 ). As mentioned above, flavofungins IV (4), VI (6), and VII (7) might derive from flavofungin I (1) by enzymatic epoxidation and hydrolysis with different configurations at H-NMR data of compounds 1-4 (500 MHz, in DMSO-d 6 , J = Hz). a Data with the same labels in each column could not be individually assigned.
Scientific RepoRts | 7: 1703 | DOI:10.1038/s41598-017-01912-z C-10 and C-11. The big differences of the coupling constants of 3 J H9−10 and 3 J H10−11 and the 13 C NMR chemical shifts of C-10 and C-11 in 4, 6, and 7 were observed, supporting that the structural differences among 4, 6, and 7 were from their different configurations at C-10 and C-11.
The relative configurations of C-15, C-17, C-19, C-21, C-23, C-25, and C-27 in 4 were initially suggested by comparison of the 13 C NMR data from 4 with the Kishi's 13 C Universal NMR database of model compounds (a-d, Fig. 2) 27, 37-39 . As shown in Table 1 The relative configurations of these 1,3-diols were also supported by the 13 C NMR chemical shifts of the dimethyl and acetal carbons in the triacetonide derivative 4a (Fig. 3) prepared from flavofungin IV (4). Usually, two distinctive NMR chemical shifts around δ C 20 and 30 for dimethyl and δ C 98 for acetal suggest a 1,3-syn diol, while a 1,3-anti diol is indicated by two identical signals near δ C 25 for dimethyl and δ C 100 for acetal 27, 28, 40 . The 13 C NMR chemical shifts (Table S3) Table S6 ) between 4S and 4R in negative values for H-8 to H-10 and positive value for H-12 were observed, suggesting a 11R configuration, while negativeΔδ S-R values for Me-14 and H-14 and positiveΔδ S-R values for H-16 and H-17 indicated a 15R configuration. Thus, the absolute configurations of 17R, 19R, 21S, 23S, 25R, and 27R were assigned based on a 15R configuration and the relative configurations of these 1,3-diols. NOE correlations of Me-14 with H-13 and H-15 observed in NOESY spectra of both 4 and 4a determined that these protons had a same β-orientation, suggesting 13S and 14R conformations. The As mentioned above, compounds 4, 6, and 7 are stereoisomers and their structural differences were from their different configurations at C-10 and C-11. Because the 11R configuration in 4 had already been assigned, the conformations of C-10 and C-11 in compounds 4, 6, and 7 could be established based on their different coupling constants of 3 J H9−10 and 3 J H10−11 and different 13 C NMR chemical shifts for C-10 and C-11 as well as NOEs. First, a large coupling constant ( 3 J H9−10 , 6.6 or 7.5 Hz) in 4 and 4a and a small coupling constant ( 3 J H10−11 , 2.9 Hz) in 4a (Tables 2 and S4 ) indicated an α-orientation for both H-10 and H-11, suggesting a 10R configuration at C-10 in 4, while a β-orientation for both H-10 and H-11 in 6 was indicated by small coupling constants of 3 J H9−10 (3.5 or 5.7 Hz) in 6 and 6a and 3 J H10−11 (3.9 Hz) in 6a (Tables 3 and S5) . Second, the 13 C NMR chemical shifts (Table 1 ) at δ 81.8 (C-10) and δ 72.0 (C-11) in 6 were quite different from their counterparts at δ 85.9 (C-10) and δ 74.7 (C-11) in 4. Furthermore, H-9 (δ 5.79) and H-11 (δ 3.89) exhibited NOE correlation in NOESY spectrum of 4a (Fig. 4B) , no NOE between H-9 (δ 5.93) and H-11 (δ 4.20) was observed in NOESY spectrum of 6a. Altogether, the data demonstrated that compounds 4 and 6 had different configurations at C-10 and C-11, which were 10R, 11R for 4 and 10S, 11S for 6. By comparison to 4 and 6, a small 3 J H9−10 (3.5 Hz) coupling constant, NOE correlation of H-9 (δ 6.01) with H-11 (δ 3.88) and no NOE between H-10 (δ 4.10) and H-11, as well as 13 C NMR chemical shifts at δ 82.6 (C-10) and δ 75.8 (C-11) suggested that 7 had 10S and 11R configurations. Based on the foregoing evidences, the structures of compounds 4, 6, and 7 were elucidated as novel polyene-polyol macrolides, named as flavofungin IV (4), VI (6), and VII (7). Their 13 (Tables 1, 3 , S3 and S5) of 8 and its triacetonide derivative 8a confirmed that 8 was very close to 4, with the absence of a methyl at C-14. The structure of 8 was thus elucidated as a new polyene-polyol macrolide, named as flavofungin VIII.
The NMR spectra of 9 showed 36 carbons for a carbonyl, ten olefinic methines, 11 oxymethines, three methines, seven methenes, and four methyls, which were same to those of 4, 6, and 7. Extensive NMR analyses confirmed that their structural differences were the tetrahydrofuran (THF) ring in 4, 6, and 7 replaced by an oxepane ring in 9. Treatment of 9 with 2,2-dimethoxypropane afforded triacetonide 9a and tetraacetonide 9b. Interpretation of the 13 C NMR chemical shifts (Table S3) (Fig. 4F, Table S6 ). Unfortunately, the results from Δδ S-R values failed to assignment the configuration at C-13, probably because the two groups of Mosher agent were too close. In the NOESY spectrum of 9a (Fig. 4D ), strong NOE correlations of H-10 (δ 3.57) with H-15 (δ 3.38), H-13 (δ 3.90) with H-11 (δ 3.31) and Me-14 (δ 0.78), and no NOE between H-10 and H-11, as well as a large coupling constant ( 3 J H10−11 , 8.8 Hz) (Table S5) suggested an α-orientation for H-10 and H-15 and an β-orientation for H-11, H-13, and Me, -14. Therefore, the configurations of C-10, C-13, C-14, and C-15 were assigned as 10S, 13S, 14R, and 15R. Based on the foregoing evidences, the structure of 9 was determined as novel polyene-polyol macrolide, named as flavofungin IX.
Compound 3 gave a [M + Na] + ion at m/z 707.3972, correspondence to a molecular formula C 36 H 60 O 12 . The general features of the NMR spectra of 3 were very similar to those of 1, indicating they were structurally related compounds. The main differences were found at the positions of C-10 and C-11, where two olefinic methines The data with the same labels in each column could not be individually assigned. of 1 were replaced by two oxymethines in 3. The UV absorption maximum at 330 nm for 3 (365 nm for 1) also supported a smaller conjugated system in 3. The configurational assignments of 11S, 13S, 14R, 15R, 17R, 19R, 21S, 23S, 25R, 27R, 30S, and 31S in 3 were achieved using the same protocol as for compounds 4-9, including 13 C Universal NMR database (Fig. 2) , 13 C NMR chemical shifts (Table S3 ) of the acetonide methyl and acetal carbons in tetraacetonide derivative 3a, NOE information (Fig. 4A) , and the same biosynthetic pathway these macrolides might have. The orientations of αH-10 and βH-11 in 3 were indicated by NOE correlations of H-11 (δ 3.70) with H-9 (δ 5.71) and H-13 (δ 4.20), and no NOE between H-11 and H-10 (δ 3.83) in 3a, as well as the large coupling constant (δ 3.79, t, 7.3 Hz, H-10) for 3 J H9−10 and 3 J H10−11 (Table 2) in 3, suggesting 10R conformation for C-10. Therefore, the structure of 3 was assigned as a new polyene-polyol macrolide, named as flavofungin III.
All isolated compounds (1-10) were evaluated by sulforhodamine B (SRB) assay for their activity in inhibiting proliferation of glioma cells U251, U87MG, SHG44, and C6. Doxorubicin (DOX) was used as a positive control. The results ( Supplementary Information, Table S2 ) indicated that flavofungins I (1) and II (2) and spectinabilin -9) were inactive. Therefore, flavofungin II (2) and spectinabilin (10) are the main components responsible for the anti-glioma activity in the crude extract. The cytotoxicity (CC 50 ) of the two active compounds 2 and 10 towards normal human astrocyte (HA) and human foreskin fibroblast (HFF-1) cells were also assayed. The results (Table S2) indicated both compounds showed a higher selectivity index (CC 50 /IC 50 ) for HA with 4.6-16.5 for 2 and 3.4-13.3 for 10, when compared to the selectivity index for HFF-1 with 1.8-6.4 for 2 and 1.3-5.1 for 10.
Compounds (1-10) were also tested for their antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300, Escherichia coli ATCC 25922, and Candida albicans by micro broth dilution method. Flavofungins I (1) and II (2) and spectinabilin (10) showed activity in suppressing the growth of C. albicans with MIC value of 12.5 μg/mL. The control drug amphotericin B had antifungal activity with MIC value of 3.125 μg/mL.
Methods
General Experimental Procedures. This section was supplied as online Supplementary Information. Strain Isolation. Strains were isolated from a sample of mangrove soils, which were collected from the Qi'ao Mangrove Forest in Zhuhai City, Guangdong, China, in October, 2013. Briefly, the dried soils (1.0 g) were diluted with sterile water to make 0.001 g/mL suspension and 200 μL suspension were covered on the surface of Gause's solid medium and then incubated at 28 °C for 10 days. The single colony was picked with sterile needles and transferred to a Gause's-agar plate. After another 10 days of growth at 28 °C, the single colony that grew well was transferred onto Gause's agar slants and stored at 4 °C until use. A total of ten strains were obtained from this mangrove sample in this study.
Preparation of Crude Extract for Bioactive Assay.
Each isolated strain was cultured in Gause's solid medium with a small Petri dish (90 mm, 25 mL medium) at room temperature for 10 days. The solid culture was cut into small pieces (about 0.6 × 0.6 cm) and then percolated with MeOH three times (50 mL, each). The combined MeOH solution was dried under reduced pressure to give crude extract. This crude extract was redissolved in DMSO to prepare crude sample (1.0 mg/mL). Sulforhodamine B (SRB) assay was used to evaluate the activity of the crude sample against the proliferation of glioma U87MG and U251 cells. The crude extract prepared from the culture of strain ZQ4BG was found to be the most active and the strain ZQ4BG was thus selected for this study.
Taxonomic identity of Streptomyces sp. ZQ4BG. The 16S rDNA sequence analysis of strain ZQ4BG was conducted by Majorbio (Shanghai, China) and its DNA sequence using BLAST (nucleotide sequence comparison) was compared to the GenBank database. The 16S rDNA sequence of strain ZQ4BG has been deposited in GenBank (accession number: KX601187). The voucher strain of Streptomyces sp. ZQ4BG was preserved at the Laboratory of Institute of Marine Biology, Ocean College, Zhejiang University, China.
Large culture of strain Streptomyces sp. ZQ4BG. Colonies of the strain ZQ4BG growing on Gause's-agar slants were inoculated into a 500 mL Erlenmeyer flask containing 200 mL of Gause's liquid medium and then incubated at 28 °C for 5 days on a rotary shaker (180 rpm) to produce seed broth. The seed broth (5 mL) was inoculated into a 500 mL Erlenmeyer flask, which contains 200 mL of Gause's liquid medium. All flasks were incubated at 28 °C for 12 days on a rotary shaker (180 rpm). A total of 60 L cultures was prepared for this study. 
Extraction and

Preparation of acetonide derivatives of flavofungins III-VI (3-6), VIII (8), and IX (9).
Pyridinium-p-toluenesulfonate (10 mg) and 2,2-dimethoxypropane (8.0 mL) were added to a solution of each flavofungin (3-6, 8, 9, 9-55 mg) in anhydrous CH 2 Cl 2 (4.0 mL) and MeOH (400 μL) at room temperature. The mixture was stirred in dark under nitrogen for 12 h and then quenched with 5% aqueous NaHCO 3 . MTPA esterification of acetonide derivatives 4a and 9a. Anti-glioma bioactive assay. Sulforhodamine B (SRB) assay as described in previous publications 9, 10 was used to evaluate the activity of all isolated compounds against the proliferation of glioma U87MG, U251, SHG44, and C6 cells as well as normal human astrocytes (HA) and human foreskin fibroblast (HFF-1). Doxorubicin (DOX, a chemotherapeutic drug) 41 was used as a positive control (CON).
Antimicrobial assay. The antimicrobial activity of the isolated compounds against growth of methicillin-resistant Staphylococcus aureus ATCC 43300, Escherichia coli ATCC 25922, and Candida albicans was assayed by the micro broth dilution method as described in previous study 13 . Gentamicin (an antibiotic against both Gram-positive and Gram-negative bacteria) and amphotericin B (an antifungal drug) were used as positive controls.
